Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Overview of attention for article published in Drugs, April 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 6 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 2 additional patents.